MA55528A - Synthèse acellulaire optimisée d'antigène b de plasmide d'invasion, compositions associées et procédés d'utilisation - Google Patents

Synthèse acellulaire optimisée d'antigène b de plasmide d'invasion, compositions associées et procédés d'utilisation

Info

Publication number
MA55528A
MA55528A MA055528A MA55528A MA55528A MA 55528 A MA55528 A MA 55528A MA 055528 A MA055528 A MA 055528A MA 55528 A MA55528 A MA 55528A MA 55528 A MA55528 A MA 55528A
Authority
MA
Morocco
Prior art keywords
antigen
compositions
methods
invasion plasmid
optimized acellular
Prior art date
Application number
MA055528A
Other languages
English (en)
Inventor
Jeffery Fairman
Neeraj Kapoor
Original Assignee
Vaxcyte Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vaxcyte Inc filed Critical Vaxcyte Inc
Publication of MA55528A publication Critical patent/MA55528A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/25—Shigella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
MA055528A 2019-04-02 2020-03-27 Synthèse acellulaire optimisée d'antigène b de plasmide d'invasion, compositions associées et procédés d'utilisation MA55528A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962828364P 2019-04-02 2019-04-02

Publications (1)

Publication Number Publication Date
MA55528A true MA55528A (fr) 2022-02-09

Family

ID=70416548

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055528A MA55528A (fr) 2019-04-02 2020-03-27 Synthèse acellulaire optimisée d'antigène b de plasmide d'invasion, compositions associées et procédés d'utilisation

Country Status (15)

Country Link
US (1) US20220125907A1 (fr)
EP (1) EP3946443A1 (fr)
JP (1) JP2022527206A (fr)
KR (1) KR20210146392A (fr)
CN (1) CN114025789A (fr)
AU (1) AU2020253332A1 (fr)
BR (1) BR112021019826A2 (fr)
CA (1) CA3135489A1 (fr)
EA (1) EA202192401A1 (fr)
IL (1) IL286819A (fr)
MA (1) MA55528A (fr)
MX (1) MX2021012120A (fr)
SG (1) SG11202110803YA (fr)
TW (1) TW202102527A (fr)
WO (1) WO2020205584A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023538365A (ja) * 2020-08-19 2023-09-07 バックスサイト・インコーポレイテッド 担体－タンパク質多糖結合方法
WO2022178015A1 (fr) * 2021-02-17 2022-08-25 Vaxcyte, Inc. Procédés de purification de polysaccharides et conjugués polypeptidiques correspondants

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0745092B1 (fr) 1993-05-28 1999-07-21 Chiron Corporation Peptides inhibiteurs de l'activite des recepteurs d'urokinase
US5972899A (en) * 1996-01-25 1999-10-26 New York University Apoptosis induced by Shigella IpaB
CN1912106A (zh) * 2005-08-09 2007-02-14 中国人民解放军军事医学科学院微生物流行病研究所 一种痢疾多价基因工程菌苗及其制备方法
CA2685729C (fr) * 2007-03-27 2016-05-31 The United States Of America As Represented By The Secretary Of The Army, Walter Reed Army Institute Of Research Invaplex artificiel
TWI365882B (en) * 2007-06-15 2012-06-11 Univ Nat Chunghsing Shigella ipab803 protein, producing method and coding nucleic acid thereof
DK2349520T3 (en) 2008-10-27 2016-08-15 Glaxosmithkline Biologicals Sa Purification Procedure for Group A Streptococcus Carbohydrate
WO2011130544A2 (fr) 2010-04-14 2011-10-20 Sutro Biopharma, Inc. Surveillance d'un système dynamique par chromatographie liquide - spectrométrie de masse
WO2013020090A2 (fr) 2011-08-04 2013-02-07 The Regents Of The University Of California Glycopolypeptides dépourvus de glcnac streptococcique, glucides de paroi cellulaire, vaccins streptococciques et procédés pour les fabriquer et les utiliser
CA2887355C (fr) 2012-10-12 2023-03-07 Sutro Biopharma, Inc. Inactivation proteolytique de proteines selectionnees dans des extraits bacteriens destines a une expression amelioree
ES2697778T3 (es) 2013-10-11 2019-01-28 Sutro Biopharma Inc ARNt sintetasas de aminoácidos no naturales para para-metilazido-L-fenilalanina
KR20170039709A (ko) * 2014-08-05 2017-04-11 글락소스미스클라인 바이오로지칼즈 에스.에이. 항원에 대한 담체 분자
KR20190103256A (ko) 2016-12-30 2019-09-04 수트로박스, 인코포레이티드 비자연 아미노산을 갖는 폴리펩타이드-항원 접합체
WO2020010016A1 (fr) * 2018-07-04 2020-01-09 Sutrovax, Inc. Conjugués immunogènes auto-adjuvés
WO2020010000A1 (fr) * 2018-07-04 2020-01-09 Sutrovax, Inc. Procédés améliorés pour la préparation de conjugués immunogènes

Also Published As

Publication number Publication date
IL286819A (en) 2021-10-31
JP2022527206A (ja) 2022-05-31
CA3135489A1 (fr) 2020-10-08
CN114025789A (zh) 2022-02-08
KR20210146392A (ko) 2021-12-03
AU2020253332A1 (en) 2021-11-25
MX2021012120A (es) 2021-11-03
BR112021019826A2 (pt) 2021-12-07
EA202192401A1 (ru) 2022-03-30
US20220125907A1 (en) 2022-04-28
WO2020205584A1 (fr) 2020-10-08
TW202102527A (zh) 2021-01-16
EP3946443A1 (fr) 2022-02-09
SG11202110803YA (en) 2021-10-28

Similar Documents

Publication Publication Date Title
MA52781A (fr) Anticorps contre entpd2, polythérapies, et procédés d'utilisation des anticorps et des polythérapies
IL280963A (en) Anti-5gdf1 antibodies, compounds and methods of use
IL287214A (en) Adeno-associated virus vector formulations and methods
MA50636A (fr) Compositions et procédés pour inhiber l'activité d'arginase
MA47522A (fr) Antigènes, vecteurs, compositions du virus de l'immunodéficience humaine et leurs procédés d'utilisation
MA56032A (fr) Composés, compositions et procédés d'utilisation
ZA202004678B (en) Compositions comprising co-selected microbiota and methods for use thereof
IL290141A (en) Formulations of anti-pvrig antibodies and uses thereof
SG11202107206RA (en) Trem compositions and uses thereof
EP3801775A4 (fr) Composition acrylique d'auto-durcissement pour le coiffage des cheveux
MA53235A (fr) Indoles substitués et procédés d'utilisation associés
MA55528A (fr) Synthèse acellulaire optimisée d'antigène b de plasmide d'invasion, compositions associées et procédés d'utilisation
MA48942A (fr) Composés thérapeutiques, compositions et procédés d'utilisation associés
MA56455A (fr) Auto-injecteur et procédés d'utilisation associés
MX2018013763A (es) Compuestos para promover crecimiento del cabello y/o inhibir o retardar perdida del cabello en humanos, y composiciones para tales usos.
MA46111A (fr) Bactéries génétiquement modifiées sécrétant des protéines thérapeutiques et procédés d'utilisation de celles-ci
IL285651A (en) Anti-trem2 antibodies, preparations containing them and their uses
ECSP21068097A (es) Anticuerpos claudina 6 y usos de los mismos
MX2021012659A (es) Composiciones de seda para el cuidado del cabello.
ZA202005143B (en) Oral formulations and uses thereof
IL288830A (en) Methods for purifying an antibody and its preparations
IL288372A (en) Modified release preparation and uses thereof
EP3966220A4 (fr) Compositions de soins personnels et leurs utilisations
MX2021006382A (es) Composiciones para el cuidado personal.
EP3867271A4 (fr) Formulations d'anticorps anti-rsv et leurs procédés d'utilisation